首页> 外文期刊>Transplant immunology >The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study
【24h】

The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study

机译:肾移植表位错配载荷的临床意义:多期学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Since the advent of kidney transplantation a key strategy for maximising graft survival by avoiding allorecognition has been to minimise HLA mismatching between donor and recipient. As HLA antibodies are now recognised as being specific for epitopes and donor-recipient HLA mismatch at the amino acid level can now be determined, HLA epitope mismatch load could be a better predictor for dnDSA development than classical HLA antigen mismatch calculation. This hypothesis has been investigated by other studies and the aim of our multicentre study was to confirm this observation in our population. Two algorithms, HLAMatchmaker and PIRCHE-II, were used to determine the HLA epitope mismatch load between donor and recipient. We have shown a significant association between the number of HLA epitope mismatches and the development of dnDSA and we have confirmed the earlier observations.
机译:由于肾移植的出现,通过避免进气释放,从而最大化移植物存活的关键策略是最小化供体和受体之间的HLA不匹配。 由于现在可以确定HLA抗体作为特异性的氨基酸水平的表位和供体 - 受体HLA失配,HLA表位错配负荷可能是DNDSA开发的更好的预测因子,而不是古典HLA抗原失配计算。 其他研究已经调查了这一假设,我们的多期面研究的目的是在我们的人口中确认这一观察。 两种算法,哈拉脉制剂和PiRche-II用于确定供体和接受者之间的HLA表位错配负载。 我们在HLA表位不匹配和DNDSA的发展之间显示了重要的关联,我们已经确认了早期的观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号